Professor Patrick W. Serruys, Thoraxcenter, Rotterdam, Joins Tryton Medical's First-in-Man Study.Thoraxcenter, Rotterdam, Uses Tryton Medical's Side-Branch Stent[TM], Treats Coronary Bifurcation Bifurcation A term used in finance that refers to a splitting of something into two separate pieces. Notes: Generally, this term is used to refer to the splitting of a security into two separate pieces for the purpose of complex taxation advantages. Lesions, Eliminates Need for Provisional Stenting NEWTON, Mass. -- Tryton Medical, Inc., the leading developer of stents designed to treat bifurcation lesions, announced that the Thoraxcenter, Rotterdam joined Tryton Medical's First-in-Man Study A first-in-man study is a clinical trial where a medical procedure, previously developed and assessed through in vitro or animal testing, or through mathematical modelling is tested on human subjects for the first time. and have successfully used Tryton's Side-Branch Stent without in-hospital complications in two patients. "Tryton's Side-Branch Stent eliminates the need for provisional side branch stenting by preserving the side branch without compromising access to the main vessel," said Professor Patrick Serruys, Head of the Department of Interventional Cardiology interventional cardiology Cardiology The subspecialty of cardiology dedicated to the diagnosis, medical and mechanical therapy, pre- and post-procedure management of adult patients with acute and chronic forms of cardiovascular disease amenable to catheter-based , Thoraxcenter, Erasmus Medical Center - Rotterdam, the Netherlands. "This technology has the capacity to redefine the treatment of bifurcation lesions and resolve a frequent dilemma of the interventional cardiologist Cardiologist Doctor who specializes in diagnosing and treating heart diseases. Mentioned in: Electrophysiology Study of the Heart, Lithotripsy cardiologist a physician who specializes in the diagnosis and treatment of heart disease. ," said Professor Serruys. "Unlike other stents and techniques used to treat bifucration lesions, Tryton's stent is easy to deliver as it uses standard equipment and techniques compatible with 5 and 6 French guiding catheters," said Dr. George Sianos, Senior Interventionalist, Thoraxcenter, Erasmus Medical Center. "This device has greatly facilitated the treatment of these patients. Interventional cardiologists who use Tryton's stent will no longer have to worry about the bifurcation as they will know the side-branch will stay open and the interventionalist is then free to focus on the treatment of the main vessel using their preferred choice of standard equipment," said Dr. Sianos. Tryton's First-In-Man Study is a multi-center clinical trial evaluating the safety of Tryton's Side-Branch Stent in the treatment of coronary bifurcation lesions. The Study is also being performed the HELIOS Heart Center/Siegburg, Germany under the direction of Prof. Eberhard Grube, Principal Investigator Noun 1. principal investigator - the scientist in charge of an experiment or research project PI scientist - a person with advanced knowledge of one or more sciences . The Institut Cardiovasulaire Paris Sud, France (Prof. Marie-Claude Morice, Principal Investigator) is scheduled to start enrollment as well. During this study, Tryton's stents have been used in conjunction with a standard workhorse work·horse n. 1. Something, such as a machine, that performs dependably under heavy or prolonged use: "the 50-year-old DC-3 ... stent to treat a wide spectrum of bifurcation lesions with superior angiographic results and without major adverse cardiac events cardiac event Coronary event Cardiology Any severe or acute cardiovascular condition including acute MI, unstable angina, or cardiac mortality . 540,000 bifurcation coronary lesions are sub-optimally treated every year as no commercially available optimized solution exists for treating bifurcation lesions. As a result, cardiologists are forced to use a provisional strategy which avoids the deployment of a second stent-- leaving the side branch vulnerable to thrombosis thrombosis (thrŏmbō`sĭs), obstruction of an artery or vein by a blood clot (thrombus). Arterial thrombosis is generally more serious because the supply of oxygen and nutrition to an area of the body is halted. and restenosis. To see pictures of pre and post-angiographic results that show the Tryton Side-Branch Stent benefits, visit www.TrytonMedical.com and click on "Save the Side Branch". About Tryton Medical, Inc. Tryton Medical, Inc. is the leading developer of stents that are designed to definitively treat bifurcation lesions. 540,000 bifurcation coronary lesions are sub-optimally treated every year with a variety of time consuming and technically challenging procedures. No optimized solution is commercially available for treating bifurcation lesions. As a result, cardiologists are forced to use a provisional strategy which avoids the deployment of a second stent-- leaving the un-stented side branch vulnerable to thrombosis and restenosis. The ability to definitively treat bifurcation lesions will enable PCI-stenting to become the new standard of care for the treatment of left main coronary artery disease coronary artery disease, condition that results when the coronary arteries are narrowed or occluded, most commonly by atherosclerotic deposits of fibrous and fatty tissue. rather than bypass surgery Bypass surgery A surgical procedure that grafts blood vessels onto arteries to reroute the blood flow around blockages in the arteries (arteriosclerosis). . Tryton Medical's Side-Branch Stent([TM]) has all the characteristics of a state-of the art workhorse stent, providing proven stent coverage to bifurcation lesions while eliminating the need for provisional stenting. For more information on Tryton Medical, Inc., contact or visit www.TrytonMedical.com |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion